SAFETY AND PHARMACODYNAMIC ACTIVITY OF A TOLL-LIKE RECEPTOR 7/8 AGONIST

摘要

Provided are methods of increasing innate and adaptive immune activation in a human subject by administering a composition comprising the TLR7/8 agonist MED 19197, preferably via intratumoral injection into a cutaneous or subcutaneous tumor.